TP53 and cancer: Then, we observed the activation of the DAPK1/p53/Ets-1/IKKβ/MDM2/GADD45α pathway in a variety of other arsenite-sensitive cancer cell lines, including HeLa (Fig. 8b), MCF7, HCT116 and A549 (Fig. S2).